Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel B Jones

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Annals of the Rheumatic Diseases|January 7, 2019
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trialRachel B Jones, Thomas F Hiemstra, Jose Ballarin, et al.
Science Advances|February 12, 2025
Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppressionKimia Kamelian, Benjamin Sievers, Michael Chen-Xu, et al.
Lancet (London, England)|June 19, 2018
Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trialGemma D Banham, Shaun M Flint, Nicholas Torpey, et al.
The Journal of Allergy and Clinical Immunology|October 27, 2016
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitisFederico Alberici, Rona M Smith, Mariana Fonseca, et al.
Rheumatology (Oxford, England)|February 26, 2020
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines-Executive summaryJoanna Tieu, Rona Smith, Neil Basu, et al.
Rheumatology (Oxford, England)|February 26, 2020
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelinesJoanna Tieu, Rona Smith, Neil Basu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2025
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitisCarol A Langford, Nader Khalidi, Jason Springer, et al.
Journal of the American Society of Nephrology : JASN|December 12, 2023
The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and TrialsSebastian Bate, Dominic McGovern, Francesca Costigliolo, et al.
Annals of the Rheumatic Diseases|March 23, 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Annals of the Rheumatic Diseases|January 7, 2019
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trialRachel B Jones, Thomas F Hiemstra, Jose Ballarin, et al.
Science Advances|February 12, 2025
Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppressionKimia Kamelian, Benjamin Sievers, Michael Chen-Xu, et al.
Lancet (London, England)|June 19, 2018
Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trialGemma D Banham, Shaun M Flint, Nicholas Torpey, et al.
The Journal of Allergy and Clinical Immunology|October 27, 2016
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitisFederico Alberici, Rona M Smith, Mariana Fonseca, et al.
Rheumatology (Oxford, England)|February 26, 2020
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines-Executive summaryJoanna Tieu, Rona Smith, Neil Basu, et al.
Rheumatology (Oxford, England)|February 26, 2020
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelinesJoanna Tieu, Rona Smith, Neil Basu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 12, 2025
A randomized, double-blind, placebo-controlled trial of abatacept for the treatment of relapsing, non-severe, granulomatosis with polyangiitisCarol A Langford, Nader Khalidi, Jason Springer, et al.
Journal of the American Society of Nephrology : JASN|December 12, 2023
The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and TrialsSebastian Bate, Dominic McGovern, Francesca Costigliolo, et al.
Annals of the Rheumatic Diseases|March 23, 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, et al.
Pageof 6